177 related articles for article (PubMed ID: 9578564)
1. Unanticipated inhibition of the metallo-beta-lactamase from Bacteroides fragilis by 4-morpholineethanesulfonic acid (MES): a crystallographic study at 1.85-A resolution.
Fitzgerald PM; Wu JK; Toney JH
Biochemistry; 1998 May; 37(19):6791-800. PubMed ID: 9578564
[TBL] [Abstract][Full Text] [Related]
2. Spectroscopic characterization of a binuclear metal site in Bacillus cereus beta-lactamase II.
Orellano EG; Girardini JE; Cricco JA; Ceccarelli EA; Vila AJ
Biochemistry; 1998 Jul; 37(28):10173-80. PubMed ID: 9665723
[TBL] [Abstract][Full Text] [Related]
3. X-ray structure of the ZnII beta-lactamase from Bacteroides fragilis in an orthorhombic crystal form.
Carfi A; Duée E; Paul-Soto R; Galleni M; Frère JM; Dideberg O
Acta Crystallogr D Biol Crystallogr; 1998 Jan; 54(Pt 1):45-57. PubMed ID: 9761816
[TBL] [Abstract][Full Text] [Related]
4. Crystal structures of the cadmium- and mercury-substituted metallo-beta-lactamase from Bacteroides fragilis.
Concha NO; Rasmussen BA; Bush K; Herzberg O
Protein Sci; 1997 Dec; 6(12):2671-6. PubMed ID: 9416622
[TBL] [Abstract][Full Text] [Related]
5. Binding of D- and L-captopril inhibitors to metallo-beta-lactamase studied by polarizable molecular mechanics and quantum mechanics.
Antony J; Gresh N; Olsen L; Hemmingsen L; Schofield CJ; Bauer R
J Comput Chem; 2002 Oct; 23(13):1281-96. PubMed ID: 12210153
[TBL] [Abstract][Full Text] [Related]
6. Structural consequences of the active site substitution Cys181 ==> Ser in metallo-beta-lactamase from Bacteroides fragilis.
Li Z; Rasmussen BA; Herzberg O
Protein Sci; 1999 Jan; 8(1):249-52. PubMed ID: 10210203
[TBL] [Abstract][Full Text] [Related]
7. Force field design and molecular dynamics simulations of the carbapenem- and cephamycin-resistant dinuclear zinc metallo-beta-lactamase from Bacteroides fragilis and its complex with a biphenyl tetrazole inhibitor.
Park H; Merz KM
J Med Chem; 2005 Mar; 48(5):1630-7. PubMed ID: 15743204
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the metal-binding sites of the beta-lactamase from Bacteroides fragilis.
Crowder MW; Wang Z; Franklin SL; Zovinka EP; Benkovic SJ
Biochemistry; 1996 Sep; 35(37):12126-32. PubMed ID: 8810919
[TBL] [Abstract][Full Text] [Related]
9. Hybrid QM/MM and DFT investigations of the catalytic mechanism and inhibition of the dinuclear zinc metallo-beta-lactamase CcrA from Bacteroides fragilis.
Park H; Brothers EN; Merz KM
J Am Chem Soc; 2005 Mar; 127(12):4232-41. PubMed ID: 15783205
[TBL] [Abstract][Full Text] [Related]
10. Complexes of thiomandelate and captopril mercaptocarboxylate inhibitors to metallo-beta-lactamase by polarizable molecular mechanics. Validation on model binding sites by quantum chemistry.
Antony J; Piquemal JP; Gresh N
J Comput Chem; 2005 Aug; 26(11):1131-47. PubMed ID: 15937993
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the zinc-dependent beta-lactamase from Bacillus cereus at 1.9 A resolution: binuclear active site with features of a mononuclear enzyme.
Fabiane SM; Sohi MK; Wan T; Payne DJ; Bateson JH; Mitchell T; Sutton BJ
Biochemistry; 1998 Sep; 37(36):12404-11. PubMed ID: 9730812
[TBL] [Abstract][Full Text] [Related]
12. The crystal structure of the L1 metallo-beta-lactamase from Stenotrophomonas maltophilia at 1.7 A resolution.
Ullah JH; Walsh TR; Taylor IA; Emery DC; Verma CS; Gamblin SJ; Spencer J
J Mol Biol; 1998 Nov; 284(1):125-36. PubMed ID: 9811546
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of extended-spectrum beta-lactamase Toho-1: insights into the molecular mechanism for catalytic reaction and substrate specificity expansion.
Ibuka AS; Ishii Y; Galleni M; Ishiguro M; Yamaguchi K; Frère JM; Matsuzawa H; Sakai H
Biochemistry; 2003 Sep; 42(36):10634-43. PubMed ID: 12962487
[TBL] [Abstract][Full Text] [Related]
14. Protonation state of Asp120 in the binuclear active site of the metallo-beta-lactamase from Bacteroides fragilis.
Dal Peraro M; Vila AJ; Carloni P
Inorg Chem; 2003 Jul; 42(14):4245-7. PubMed ID: 12844290
[TBL] [Abstract][Full Text] [Related]
15. Bulgecin A: a novel inhibitor of binuclear metallo-beta-lactamases.
Simm AM; Loveridge EJ; Crosby J; Avison MB; Walsh TR; Bennett PM
Biochem J; 2005 May; 387(Pt 3):585-90. PubMed ID: 15569001
[TBL] [Abstract][Full Text] [Related]
16. Structure of the SHV-1 beta-lactamase.
Kuzin AP; Nukaga M; Nukaga Y; Hujer AM; Bonomo RA; Knox JR
Biochemistry; 1999 May; 38(18):5720-7. PubMed ID: 10231522
[TBL] [Abstract][Full Text] [Related]
17. Irreversible inhibition of metallo-beta-lactamase (IMP-1) by 3-(3-mercaptopropionylsulfanyl)propionic acid pentafluorophenyl ester.
Kurosaki H; Yamaguchi Y; Higashi T; Soga K; Matsueda S; Yumoto H; Misumi S; Yamagata Y; Arakawa Y; Goto M
Angew Chem Int Ed Engl; 2005 Jun; 44(25):3861-4. PubMed ID: 15892033
[No Abstract] [Full Text] [Related]
18. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
Weston GS; Blázquez J; Baquero F; Shoichet BK
J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationship of 6-methylidene penems bearing tricyclic heterocycles as broad-spectrum beta-lactamase inhibitors: crystallographic structures show unexpected binding of 1,4-thiazepine intermediates.
Venkatesan AM; Gu Y; Dos Santos O; Abe T; Agarwal A; Yang Y; Petersen PJ; Weiss WJ; Mansour TS; Nukaga M; Hujer AM; Bonomo RA; Knox JR
J Med Chem; 2004 Dec; 47(26):6556-68. PubMed ID: 15588091
[TBL] [Abstract][Full Text] [Related]
20. Metallo-beta-lactamases (classification, activity, genetic organization, structure, zinc coordination) and their superfamily.
Bebrone C
Biochem Pharmacol; 2007 Dec; 74(12):1686-701. PubMed ID: 17597585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
